Virnich Daniel 4
4 · Oncology Institute, Inc. · Filed May 23, 2024
Insider Transaction Report
Form 4
Virnich Daniel
Chief Executive Officer
Transactions
- Disposition to Issuer
Common Stock
2024-05-21$0.60/sh−11,173$6,673→ 718,430 total - Award
Common Stock
2024-05-21+198,517→ 916,947 total - Award
Non-Qualified Stock Option (right to buy)
2024-05-21+496,293→ 496,293 totalExercise: $2.00Exp: 2034-05-21→ Common Stock (496,293 underlying)
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) pursuant to a sell-to-cover provision included in the RSU Agreement.
- [F2]Represents RSUs with 1/4th of the RSUs vesting on the first anniversary of the Vesting Commencement Date, with the remaining RSUs vesting in three equal annual installments beginning on the first anniversary of the Vesting Commencement Date, with all RSUs becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates.
- [F3]The stock options vest as to 1/4th of the options granted on the first anniversary of the Vesting Commencement Date, with the remaining options vesting in three equal annual installments beginning on the first anniversary of the Vesting Commencement Date, with all options becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates.